Mh. Lyttle et al., ISOZYME-SPECIFIC GLUTATHIONE-S-TRANSFERASE INHIBITORS - DESIGN AND SYNTHESIS, Journal of medicinal chemistry, 37(1), 1994, pp. 189-194
Glutathione-S-transferase (GST) isozyme-selective inhibitors were desi
gned by an empirically guided strategy. In the first phase, literature
data were used to select 6-terminal modifications which generated max
imum variation in the catalytic efficiency (V-max/K-m) for glutathione
(GSH) analogs cased as substrates with different rat GSTs. Also, on t
he basis of literature data, the sulfhydryl group was functionalized w
ith a selection of alkyl and aryl groups to maximize potential isozyme
specificity. affinity. chromatography sorbents were prepared from the
se which showed isozyme selectivity for both rat tissue and recombinan
t human GST isozymes. Some of these compounds also showed selective in
hibition of GST activity in catalysis of the reaction of 1-chloro-2,4-
dinitrobenzene with GSH. In the second phase, electronic effects were
explored through synthesis of an isostructural series of S-benzyl GSH
ligands with different substituents on the aromatic ring. GST isozyme
specificity for these ligands, measured by binding to derivatized sorb
ents, varied substantially, with hydrophobic substituents favoring the
human GST M1a isozyme and electronegative moieties favoring GST P1. I
n the third phase, information obtained from testing both series of co
mpounds was combined and used to prepare GSH analogs with chemical fea
tures responsible for isozyme specificity at both the C-terminus and t
he sulfur. This approach gave two new compounds which showed improved
potency while still maintaining selectivity in the inhibition of GSTs.
A detailed discussion of the logic used in the selection of functiona
l groups for maximum potency and selectivity is included.